Thursday February 21, 2019

China Develops new Diagnostic Method for Coronary Heart Disease

Coronary angiography is the most conventional diagnostic method of coronary heart diseases. However, the internationally recognized high-precision assessment technology is expensive and requires complex surgical procedures

0
//
heart disease
Representational image. (IANS)

Researchers have developed a new method for diagnosing coronary heart disease with 33 per cent higher accuracy rate as compared with conventional methods.

Developed by Shanghai Jiao Tong University, the new technology is called Quantitative Flow Ratio (QFR) measurement system and has been approved by the China Food and Drug Administration, Xinhua news agency reported on Monday.

Based on the computational analysis of an X-ray coronary angiography image, the system obtains the QFR, which can help identify coronary heart disease.

The new method does not require additional surgeries or drugs, the report said.
The new method does not require additional surgeries or drugs, the report said. (IANS)

“The new method will assist doctors in identifying coronary heart disease and assist in making treatment plans, such as whether the patient needs a heart stent implantation,” Chen Yazhu from the varsity was quoted as saying.

Coronary angiography is the most conventional diagnostic method of coronary heart diseases. However, the internationally recognized high-precision assessment technology is expensive and requires complex surgical procedures.

Also Read: Air Pollution Linked to Changes in Heart Structure

A clinical study, led by Fuwai Hospital of the Chinese Academy of Medical Sciences, showed that the new method could assess coronary function within four minutes, and had a 33 per cent higher accuracy rate as compared with a coronary angiography. (IANS)

Next Story

U.S. Trade Representative To Corroborate on China

In a statement, the committee said the hearing was scheduled for Feb. 27, just days ahead of President Donald Trump's March 1 deadline that the Republican U.S. leader has said could slide.

0
U.S.
"Awareness about cervical cancer is extremely poor among common people; that makes containing the disease a challenge," Anjila Aneja, Director at Fortis La Femme, New Delhi, told IANS. VOA

U.S. Trade Representative Robert Lighthizer will testify next week at a U.S. House of Representatives hearing on U.S.-China trade issues, a spokesman for the House Ways and Means Committee said on Wednesday.

U.S.
In a statement, the committee said the hearing was scheduled for Feb. 27, just days ahead of President Donald Trump’s March 1 deadline that the Republican U.S. leader has said could slide. VOA

Lighthizer has been the lead negotiator in ongoing trade negotiations with Beijing as the world’s two largest economies seek to find agreement amid a bitter dispute that has seen both sides impose tariffs on imports.

In a statement, the committee said the hearing was scheduled for Feb. 27, just days ahead of President Donald Trump’s March 1 deadline that the Republican U.S. leader has said could slide.

Also Read: Know How Venezuela Can Restore Back Its Economy

China and the United States began their latest round of talks this week. (VOA)